IntrinsicIntrinsic
← All summaries

Vita Coco Company, Inc.

COCO
Financials & Chart →

Business Summary

The Vita Coco Company, Inc. operates within the functional beverages industry, with its primary brand, Vita Coco Coconut Water, competing in the global coconut and plant waters category. The company also offers Vita Coco coconut milk as a plant-based dairy alternative and its PWR LIFT brand in the enhanced isotonic category. The broader beverage industry, particularly functional beverage categories, is significantly larger than the coconut and plant waters category, presenting opportunities for potential growth. The company believes that per capita consumption of natural beverages is increasing due to rising consumer interest in hydration and preferences for health-conscious products with fewer added sugars and artificial ingredients, while offering more functional benefits. Additionally, increased consumer awareness of the environmental and social impact of packaged goods has led to higher demand for purpose-driven brands focused on sustainable packaging and ethical values, aligning with Vita Coco's mission.

The beverage industry is highly competitive and constantly evolving. Competition is primarily based on brand recognition, taste, quality, price, availability, selection, convenience, corporate responsibility, and sustainability. Vita Coco's flagship brand is the market leader in the U.S. coconut water category with greater than 40% market share as of December 28, 2025, and also leads the U.K. coconut water category with 80% market share as of December 27, 2025. The company competes with other coconut water brands such as Goya, Harmless Harvest, Zico, and C20, as well as emerging brands and retailers' Private Label beverage brands. The company is also a large supplier of Private Label coconut water and competes with other Private Label suppliers for this business.

The company's core business model revolves around developing, marketing, and distributing coconut water branded and Private Label products, along with other "better-for-you" beverages. Revenue is generated through sales to distributors and retailers, including club, food, drug, mass, convenience, e-commerce, and on-premise locations. The company operates with an asset-light supply chain model, engaging contract manufacturers, co-packers, and third-party logistics providers. This model is designed to enhance production flexibility and capacity, allowing the company to focus on supplier management, logistics, sales, marketing, brand management, and customer service. The company's global manufacturing network includes approximately 16 coconut water factories across six countries and six co-packing facilities in three countries. The company also generates revenue from bulk product sales to beverage and food companies.

The Vita Coco Coconut Water product category encompasses all branded coconut water offerings where coconut water is the majority ingredient, including Vita Coco Extra Coconut, Vita Coco Coconut Juice, and Farmers Organic. This category contributed $496.262 million to consolidated net sales in 2025, representing a significant portion of total revenue. The strategic role of this category is to expand the coconut water market through consumer education on usage occasions and benefits, increase distribution of existing offerings, launch new product innovations like Vita Coco Treats, expand household penetration, and grow global markets.

The Private Label product category includes coconut water and coconut oil offerings supplied to key retailers. This segment generated $88.682 million in consolidated net sales in 2025. The strategic purpose of the Private Label business is to develop stronger ties with strategic retail partners, increase the scale and efficiency of the coconut water supply chain, and capture a share of the value segment without diluting the company's own brand. The "Other" product category, which includes Vita Coco product extensions beyond coconut water such as coconut milk products (including Vita Coco Treats), PWR LIFT, Ever & Ever (ceased production in 2024), Runa (ceased selling in December 2023), Vita Coco coconut oil sold internationally, and bulk product sales, contributed $24.836 million to consolidated net sales in 2025. PWR LIFT is a protein-infused sports drink with electrolytes, BCAAs, and zero sugar, targeted at post-workout and recovery occasions.

For the fiscal year ended December 31, 2025, the company reported total net sales of $609.780 million , an increase from $516.013 million in 2024. Gross profit was $222.595 million , resulting in a consolidated gross margin of 36.5% . Operating expenses, primarily selling, general and administrative expenses, totaled $140.063 million . Income from operations was $82.532 million . Net income for the period was $71.320 million , leading to diluted EPS of $1.19 . Cash and cash equivalents stood at $196.873 million as of December 31, 2025. The company had an immaterial amount of outstanding debt related to vehicle loans and no outstanding balance on its $60 million revolving credit facility. Cash flows provided by operating activities were $47.174 million .

Year-over-year, total net sales increased by $93.767 million , or 18.2% , from 2024 to 2025. This growth was driven by higher coconut water CE volumes across both the Americas and International segments, including Vita Coco Coconut Water volume growth of 21.3% and increased Vita Coco Coconut Water pricing. The Americas segment net sales increased by $66.430 million , or 15.0% , while the International segment net sales increased by $27.337 million , or 37.1% . Consolidated gross profit increased by $23.812 million , or 12.0% , but the consolidated gross margin decreased by 2.0 percentage points to 36.5% , primarily due to increased product costs and the impact of tariffs, partially offset by Vita Coco Coconut Water pricing and favorable product mix from lower Private Label volumes. Selling, general and administrative expenses increased by $15.100 million , or 12.1% . Private Label net sales in the Americas segment decreased by $27.169 million , or 30.2% , due to lost regions with key retailers, while International Private Label net sales increased by $6.627 million , or 34.3% . Net sales for "Other" products in the Americas segment increased by $12.568 million , or 137.3% , driven by the national launch of Vita Coco Treats.

During the reported period, the company ceased selling the Runa brand in December 2023 and impaired all remaining assets in September 2025. Production of Ever & Ever, a sustainably packaged water, ceased in 2024. In 2024, Vita Coco Treats, a coconut milk-based drink, was introduced and expanded to national distribution in 2025. The company's Board approved an additional $25.0 million to its share repurchase program on April 28, 2025, increasing the total authorization to $65.0 million . The company repurchased 363,930 shares at a cost of $11.3 million during 2025. The Credit Facility was amended on February 14, 2025, extending its maturity five years to February 13, 2030.

Business Outlook

The company believes that the growth of its business and future success are dependent on several key factors, including managing risks associated with its supply chain and shipping, consumer demand and relationships with key customers, and the ability to generate growth through product innovation. The asset-light supply chain model is integral to efficient scaling and competition, allowing for effective management of total delivery costs and greater flexibility to shift volume between suppliers to optimize the supply chain. The company's scale of sourcing is expected to continue to provide capacity and reliable service to retailers.

The company's innovation efforts will focus on developing and marketing product extensions, improving the quality and taste profiles of existing products, and introducing new products or brands to meet evolving consumer needs. For example, the company introduced Vita Coco Treats in 2024 and expanded its national distribution in 2025, indicating a continued focus on new product launches and market penetration for these innovations. The company maintains in-house research and development capabilities and strong third-party relationships with flavor development houses to support continued innovation.

Operationally, the company intends to continue improving its efficiency and leverage its brand position across channels, with a balanced approach to investment and development in both retail and e-commerce execution. The Direct Store Delivery (DSD) network remains an important asset for executing physical retail programs and ensuring product availability and visibility in the U.S. The company will continue to expand its e-commerce business, including its Direct-to-Consumer (DTC) channel, and adapt its approaches to changing consumer and retail behavior to maintain competitiveness and visibility across all channels. In 2026, the company plans to continue online sales of PWR LIFT while redesigning its approach to succeeding in the protein drink category.

Regarding capital allocation, the Board approved an additional $25.0 million to the share repurchase program on April 28, 2025, bringing the total authorization to $65.0 million . As of December 31, 2025, approximately $40.9 million remained available for future purchases under this program. The company currently intends to retain all available funds and future earnings to finance operations and business expansion, and any authorized share repurchases, and does not anticipate declaring or paying any dividends in the foreseeable future. The Credit Facility, which provides for committed borrowings of $60 million , was amended to extend its maturity to February 13, 2030, with no outstanding balance as of December 31, 2025.

The company faces structural headwinds and execution risks, particularly related to its supply chain and shipping. Uncertainty in the macroeconomic environment, including geopolitical and economic instability, high interest rates, foreign exchange rates, tariffs, and inflationary cost environments, may affect the global supply chain. The company experienced $16 million of tariffs paid in 2025, although U.S. executive actions in November 2025 granted tariff exemptions for coconut water products, significantly reducing the tariff burden post-November 21, 2025. However, these exemptions may be temporary or subject to change. The company also experienced significant cost increases and supply constraints in transportation in 2024 due to geopolitical disruption, leading to instability in pricing and increased transit times. While rates declined towards pre-pandemic levels by the end of 2025, periodic cost surges on ocean freight costs were unexpected. The company may not be able to pass such increases on to customers without impacting volume, revenue, margins, and operating results.

The company is also subject to customer concentration risk, with two customers representing approximately 44% of consolidated net sales in 2025. The discontinuation of a Private Label coconut oil supply relationship with one significant customer in early 2024, and the loss of some Private Label coconut water regions with this customer in 2025, highlight the uncertainty in the Private Label segment. However, this customer has requested to restart supply in early 2026 for one of the lost regions, illustrating the unpredictable nature of this business. The company's ability to maintain or extend contractual relationships with distributors and retail customers on attractive terms is not guaranteed, and the loss of any part of a key customer's Private Label business could negatively impact support for branded products.

Risk Factors

The company faces several material risks, including a reduction in demand for its coconut water products, which accounted for 96% of revenue in 2025, or a general decrease in consumer demand for coconut water. Supply chain interruptions, inflation, and tariffs, such as the $16 million in tariffs paid in 2025, can increase shipping expenses and product costs, adversely affecting profitability. The company is highly dependent on its ability to forecast and manage inventory levels effectively, as product takes many weeks to arrive from manufacturing partners, requiring planning as much as six months in advance. Reduced or limited availability of coconuts and other raw materials, vulnerable to adverse weather, natural disasters, and political events, could increase costs and reduce supply. The company relies on a single supplier, Tetra Pak, for the majority of its packaging materials, creating dependency and potential for volatility in costs. Customer concentration is a significant risk, with two customers accounting for approximately 44% of total net sales in 2025 and 39% of total accounts receivable as of December 31, 2025. The highly competitive food and beverage industry, with large multinational competitors, poses a threat to market share and margins. Failure to develop and maintain brands, introduce new products, or respond to changing consumer preferences could harm the business. Pandemics, epidemics, or global trade disruptions can disrupt supply chains and production processes. The international nature of the business exposes the company to foreign exchange volatility, with a 10% strengthening or weakening of the U.S. dollar estimated to result in an approximately $9.5 million gain or loss on derivative instruments as of December 31, 2025. Compliance with extensive government regulations, including food safety, labeling, and anti-corruption laws, is critical, and non-compliance could lead to significant liabilities. Cybersecurity risks, including attacks and data breaches, could result in financial losses, litigation, and reputational harm. The company's status as a Delaware public benefit corporation requires balancing stockholder pecuniary interests with public benefits, which may impact financial performance or increase legal risk, including potential derivative litigation if directors are perceived to fail in balancing these interests.

Management Priorities

Management's message emphasizes the company's mission to deliver great tasting, natural, and nutritious products that are better for consumers and the world, aligning with increasing consumer interest in health-conscious and purpose-driven brands. They highlight the company's leadership position in the coconut water category, with Vita Coco holding over 40% market share in the U.S. and 80% in the U.K. Management is focused on leveraging its asset-light supply chain model to efficiently scale the business and adapt to market changes, despite facing macroeconomic uncertainties such as tariffs, which amounted to $16 million in 2025, and fluctuating transportation costs. A key strategic priority is to drive growth through product innovation, including the national launch of Vita Coco Treats, and to continuously improve existing products to meet evolving consumer preferences. Management also stresses a balanced approach to investment and development in both retail and e-commerce channels to ensure competitiveness and visibility. They are committed to maintaining strong relationships with key customers, acknowledging the risk of customer concentration, where two customers represented approximately 44% of total net sales in 2025.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Vita Coco
  2. [2] Item 1, Business — Vita Coco
  3. [3] Item 7, MD&A — Disaggregation of Revenue
  4. [4] Item 7, MD&A — Disaggregation of Revenue
  5. [5] Item 7, MD&A — Disaggregation of Revenue
  6. [6] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  7. [7] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  8. [8] Item 7, MD&A — Gross Profit
  9. [9] Item 7, MD&A — Gross Profit
  10. [10] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  11. [11] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  12. [12] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  13. [13] Item 8, Note 17 — Earnings Per Share
  14. [14] Item 7, MD&A — Liquidity and Capital Resources
  15. [15] Item 7, MD&A — Debt
  16. [16] Item 7, MD&A — Revolving Credit Facility
  17. [17] Item 7, MD&A — Cash Flows
  18. [18] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  19. [19] Item 7, MD&A — Results of Operations Comparison of the Years Ended December 31, 2025 and 2024
  20. [20] Item 7, MD&A — Volume in Case Equivalent
  21. [21] Item 7, MD&A — Americas Segment
  22. [22] Item 7, MD&A — Americas Segment
  23. [23] Item 7, MD&A — International Segment
  24. [24] Item 7, MD&A — International Segment
  25. [25] Item 7, MD&A — Gross Profit
  26. [26] Item 7, MD&A — Gross Profit
  27. [27] Item 7, MD&A — Gross Profit
  28. [28] Item 7, MD&A — Selling, General and Administrative Expenses
  29. [29] Item 7, MD&A — Selling, General and Administrative Expenses
  30. [30] Item 7, MD&A — Americas Segment
  31. [31] Item 7, MD&A — Americas Segment
  32. [32] Item 7, MD&A — International Segment
  33. [33] Item 7, MD&A — International Segment
  34. [34] Item 7, MD&A — Americas Segment
  35. [35] Item 7, MD&A — Americas Segment
  36. [36] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  37. [37] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  38. [38] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  39. [39] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  40. [40] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  41. [41] Item 7, MD&A — Risks Associated with our Supply Chain and Shipping
  42. [42] Item 8, Note 11 — Major Customers
  43. [43] Item 1A, Risk Factors — Risks Related to Our Business and Industry
  44. [44] Item 8, Note 2 — Concentration of Credit Risk
  45. [45] Item 7A, Quantitative and Qualitative Disclosures About Market Risk — Foreign Currency Exchange Risk

Analysis on 5/20/2026